fluoromisonidazole has been researched along with Chordoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YL; Cheney, MD; DeLaney, TF; Depauw, N; Grosu, AL; Hornicek, FJ; Lim, R; Schwab, JH; Shih, HA; Trofimov, AV; Winrich, BK | 1 |
| Clemenceau, S; Ferrand, R; Feuvret, L; George, B; Habrand, JL; Kerrou, K; Lot, G; Mammar, H; Mazure, N; Mokhtari, K; Nataf, V; Polivka, M; Pontvert, D; Pouysségur, J; Talbot, JN | 1 |
2 trial(s) available for fluoromisonidazole and Chordoma
| Article | Year |
|---|---|
[18F]-Fluoromisonidazole positron emission tomography/computed tomography visualization of tumor hypoxia in patients with chordoma of the mobile and sacrococcygeal spine.
Topics: Adult; Aged; Cell Hypoxia; Chordoma; Feasibility Studies; Female; Humans; Male; Middle Aged; Misonidazole; Multimodal Imaging; Neoplasm Recurrence, Local; Photons; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Proton Therapy; Radiopharmaceuticals; Radiotherapy Dosage; Relative Biological Effectiveness; Sacrococcygeal Region; Spinal Neoplasms; Tomography, X-Ray Computed; Tumor Burden | 2014 |
Positron emission tomography/computed tomography imaging of residual skull base chordoma before radiotherapy using fluoromisonidazole and fluorodeoxyglucose: potential consequences for dose painting.
Topics: Adult; Cell Hypoxia; Chordoma; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Misonidazole; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Skull Base Neoplasms; Tomography, X-Ray Computed; Young Adult | 2012 |